Biostatistics Podcast

Jocelyn Chen
Biostatistics Podcast

A biostatistics podcast made by biostatistics enthusiast about all biostatistics topics! Powered by Firstory Hosting

  1. 6 SEP.

    #16 Biostatistics Podcast with Avery McIntosh and Alex Sverdlov

    What are gene therapies? What are some recent advancement in gene therapy? How does development in gene therapy differ from common drugs? Today's episode is slightly different from the previous ones. It is the first time that TWO brilliant biostatisticians share their insight in the same episode! Avery McIntosh and Alex Sverdlov will answer all the questions about gene therapy for you! Dr. McIntosh is currently engaged in drug development for rare diseases at Pfizer, where he leads a team of statisticians working across different study phases and a range of drug types and disease areas. Meanwhile, Dr. Sverdlov serves as the Neuroscience Disease Area statistical lead at Novartis, where he focuses on methodological research and the application of innovative statistical methods in drug development. Other than an interesting gene therapy 101 that Avery and Alex gave in this episode, they also recently co-published a book called "Development of gene therapies: strategic, scientific, regulatory, and Access considerations", which is now available. I will put the link of the book in the show notes and please check it out if you are either a long term enthusiast of gene therapy or if you start to think gene therapy is interesting after listening to this episode. Let dive into this episode and see what Avery and Alex have shared with us. You can find Avery and Alex's new book here. Please visit our website https://biostatisticspodcast.github.io/ for the latest updates and transcripts of the published episodes. If you have any comments, feedback, or suggestions, feel free to email us via biostatisticspodcast@gmail.com or DM us on Twitter @BiostatsPodcast Powered by Firstory Hosting

    44 min
  2. 2023-06-19

    #9 Biostatistics Podcast with Paul Arora

    What's the difference between epidemiology and biostatistics? What do epidemiologists support in a consulting company? How to build a start-up with your statistical knowledge? Dr. Paul Arora will answer all these questions for you! Paul holds the position of Vice President, Advanced Epidemiology at Cytel, where his primary areas of focus encompass real-world evidence, epidemiological methods, and the application of machine learning to health outcome issues. Additionally, he played a significant role in establishing Lighthouse Outcomes, a specialized consulting firm dedicated to advanced analytics in clinical epidemiology research. Moreover, Paul is an Assistant Professor within the Division of Epidemiology at the Dalla Lana School of Public Health, University of Toronto. His professional background is rooted in epidemiology, with over fifteen years of experience leading assessments in both public health and clinical epidemiology. He possesses extensive expertise in evidence synthesis methodologies and has held influential consulting positions, collaborating with domestic and international public and private institutions. Let's dive into this episode and see what Paul shared with us! Please visit our website https://biostatisticspodcast.github.io/ for the latest updates and transcripts of the published episodes. If you have any comments, feedback or suggestions, feel free to email us via biostatisticspodcast@gmail.com or DM us on Twitter @BiostatsPodcast Powered by Firstory Hosting

    59 min

Om

A biostatistics podcast made by biostatistics enthusiast about all biostatistics topics! Powered by Firstory Hosting

Logga in för att lyssna på vuxet innehåll.

Följ programmet

Logga in eller registrera dig för att följa program, spara avsnitt och få de senaste uppdateringarna.

Välj land eller region

Afrika, Mellanöstern och Indien

Stillahavsområdet

Europa

Latinamerika och Karibien

USA och Kanada